Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q3 2023 · 10-Q
Revenue$79.07M$79.07M+16.7% vs Q3 2022 Net Income-$158.93M-$158.93MN/M vs Q3 2022 EPS Diluted-$1.11-$1.11N/M vs Q3 2022 Operating Income-$147,668,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$139,187,000N/M Margins · derivedOperating margin-186.8%+1.8 pt vs Q3 2022
Net margin-201.0%−7.4 pt vs Q3 2022
ended Sep 30, 2023 · filed Oct 26, 2023 · 26 d after period end